Navigation Links
NHP Reports 2009 First Quarter Results
Date:5/7/2009

First Quarter Highlights

- Upgraded by Fitch to BBB

- Upgraded by Moody's to Baa2

- Standard & Poors Upgrade Outlook to Positive

- Balance Sheet Remains Strong With Modest Capital Commitments Through July 2011

- Maintaining Quarterly Cash Dividend of $0.44 per Share

- Diluted FFO Payout Ratio of 77%

NEWPORT BEACH, Calif., May 7 /PRNewswire-FirstCall/ -- Nationwide Health Properties, Inc. (NYSE: NHP) today announced results of operations for the first quarter ended March 31, 2009. Contemporaneously with this press release, the Company has filed its Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2009 with the Securities and Exchange Commission.

"In the current economic environment, the balance sheet is center stage with premiums placed on low leverage and ample liquidity. As evidenced by recent credit rating upgrades from Moody's and Fitch, NHP's balance sheet is strong. On an enterprise value basis, our leverage is a conservative 40% and we have ample liquidity with about $80 million of cash and the full capacity of our $700 million credit facility," commented Douglas M. Pasquale, NHP's Chairman and Chief Executive Officer. "We believe the investment environment favors patience and the difficult economy requires extra attention allocated to our existing assets and tenants. In time we believe that assets will be available at attractive prices, and we expect to make excellent investments as opportunities present themselves," Mr. Pasquale added.

FIRST QUARTER 2009 RESULTS OF OPERATIONS

The following table presents selected unaudited financial information for the first quarter and the year ended March 31, 2009 as compared to th
'/>"/>

SOURCE Nationwide Health Properties, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine news :

1. Cardium Reports on New Excellarate(TM) Product Formulations to Expand Commercialization Potential Into Multiple Wound Healing Applications
2. PLC Systems Reports First Quarter 2009 Results
3. Perrigo Reports Record Third Quarter
4. Symmetry Medical Reports First Quarter 2009 Financial Results
5. Orchid Cellmark Reports Improved First Quarter 2009 Financial Results
6. Labopharm Reports Results for First Quarter Fiscal 2009
7. Isis Reports Strong Financial Results and Highlights for First Quarter of 2009
8. Cornerstone Therapeutics Reports First Quarter 2009 Financial Results
9. Stereotaxis Reports First Quarter 2009 Financial Results
10. Cell Therapeutics Reports 76% Decrease in First Quarter 2009 Net Loss Attributable to Common Shareholders; Completion of Pixantrone NDA Submission on Track for Second Quarter 2009
11. The Ensign Group Reports First Quarter 2009 Earnings of $0.38 per Share; Reaffirms 2009 Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... (PRWEB) March 31, 2015 Medical DNA ... has met all criteria for Laboratory Accreditation by COLA, ... only to laboratories that apply rigid standards of quality ... of proficiency testing, and pass a rigorous on-site laboratory ... accreditation as a result of a long-term commitment to ...
(Date:3/31/2015)... 31, 2015 Students, teachers, and the ... education in a drastically different way as current and ... and training content is being delivered and received. , ... technology in an unprecedented way with education becoming individualized, ... co-founder and CEO, My Mobile University , This ...
(Date:3/31/2015)... Clinovo, a leading provider of ... , the premiere voice of Northern California’s Life ... companies. , BayBio brings together the collective ... and productive life science cluster, helping companies grow, ... most pressing challenges. , “We are thrilled ...
(Date:3/31/2015)... 31, 2015 Dr. Russell Ashinoff is a ... He was recently quoted in an Asbury Park Press ... issues, causing fluid retention and tissue swelling. Dr. Ashinoff ... and / or improve lymphedema symptoms. , “The ... the symptoms of lymphedema. The goal is to improve ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 Dr. Uzma Parvez ... March 19th, Dr. Parvez conducted Grand Grounds Presentations at St. ... Opioids and Managing Side Effects”. The event was attended ... She received very positive feedback from the Grand Rounds. ... best that they’ve had in a while. , Ahead, ...
Breaking Medicine News(10 mins):Health News:Local Medical DNA Labs, LLC. Recognized for Quality Laboratory Services 2Health News:LTT Global Communications Launches First Asia Holistic Online Learning Platform 2Health News:LTT Global Communications Launches First Asia Holistic Online Learning Platform 3Health News:Clinovo Joins BayBio Membership Program, The Leading Life Science Association in Northern California 2Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 2Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 3Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 4Health News:NJ Top Docs Presents, Dr. Uzma Parvez of Total Pain Care 2
... organizations have called on the medical profession to ... health between Indigenous and non-Indigenous Australians . ... of Australia, Dr Mark Wenitong, President of the ... the National Aboriginal Community Controlled Health Organization and ...
... Indigenous mothers living in remote areas are 14 per cent ... in regional or city areas say Indigenous health researchers ... Womens and Childrens Health at the University of New South ... Welfare National Perinatal Statistics Unit and her colleagues, examined whether ...
... the brain to sensitize people to overreact to an ... people who dont have a stress-related disorder, says new ... have long lasting effects on the brain and behavior ... But these subtle changes could increase susceptibility to mental ...
... the growing epidemic of diabetes in the US is out. ... . ,According to a drug trend report released ... cholesterol medications in total prescription drug spending growth in 2006. ... obesity a leading cause of diabetes are expected ...
... in the mouth like a popular breath-freshener could someday ... The innovative drug-delivery system was developed by Johns ... two-semester course, the seven-student team fabricated a thin film ... the child to swallow the vaccine. The dissolved medication ...
... become one of the first major universities in the country ... University officials intend to give the Fayetteville campus community ... the policy: the ban is scheduled to go into effect ... issue, said Mary Alice Serafini, assistant vice chancellor for student ...
Cached Medicine News:Health News:Trauma Exposure can Affect Brain Function Several Years After Event 2Health News:Spending on Diabetes Drugs Soars in US 2Health News:Students Devise Oral Quick-dissolve Strips for Rotavirus Vaccine 2Health News:Students Devise Oral Quick-dissolve Strips for Rotavirus Vaccine 3Health News:University of Arkansas to Ban Tobacco from Its Campus 2Health News:University of Arkansas to Ban Tobacco from Its Campus 3
(Date:3/31/2015)... , March 31, 2015 Accelerated ... the American Association of Orthodontics 2015 Annual Session, ... orthodontists present scientific lectures on AcceleDent ® . ... leader in accelerated orthodontics, AcceleDent is a FDA-cleared, ... treatment by as much as 50 percent with ...
(Date:3/31/2015)... DALLAS , March 31, 2015 ... H1 2015" therapeutic market research report of 68 ... its online business intelligence library. The ... information on the therapeutic development for Pemphigus ... therapeutics assessment by drug target, mechanism of action ...
(Date:3/31/2015)... Ryan & Maniskas, LLP is ... Hyperion Therapeutics, Inc. ("Hyperion" or the "Company") (NASDAQ: ... other violations of law related to the Company,s efforts ... a transaction valued at approximately $1.1 billion. ... to learn more about this class action or if ...
Breaking Medicine Technology:Leading Orthodontists to Advance Accelerated Treatment at AAO 2015 2Leading Orthodontists to Advance Accelerated Treatment at AAO 2015 3Pemphigus Therapeutic Development and Pipeline Review H1 2015 2Pemphigus Therapeutic Development and Pipeline Review H1 2015 3Pemphigus Therapeutic Development and Pipeline Review H1 2015 4Ryan & Maniskas, LLP Announces Investigation of Hyperion Therapeutics, Inc. 2
... 25, 2011 Renowned biochemist Michael A. Marletta, ... as the next president of The Scripps Research Institute, effective ... MD, who has led the institution for 25 years. ... Marletta, past Chair of the Department of ...
... 2011 ERT (Nasdaq: ERES ), announced ... CEO, and Keith Schneck, the Company,s Chief Financial Officer, ... Health Care Conference at 10:00 AM ET on March 2, ... may access the presentation by visiting the Company,s corporate ...
Cached Medicine Technology:The Scripps Research Institute Names Michael A. Marletta as President 2The Scripps Research Institute Names Michael A. Marletta as President 3The Scripps Research Institute Names Michael A. Marletta as President 4ERT to Present at the Citi 2011 Global Health Care Conference on March 2, 2011 2
...
View Mex-2 is designed for out-patient surgery, hospital rounds and house calls....
It is a magnifying headlight perfect for all applications and procedures where clear magnification and a natural white light increase accuracy and productivity....
... is powerful, lightweight, easy ... soft, durable foam silicone ... covered by machine washable ... headband easily adjusts to ...
Medicine Products: